Human prion diseases:: epidemiology and integrated risk assessment

被引:50
作者
Glatzel, M
Ott, PM
Linder, T
Gebbers, JO
Gmür, A
Wüst, W
Huber, G
Moch, H
Podvinec, M
Stamm, B
Aguzzi, A
机构
[1] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Natl Reference Ctr Prion Dis, CH-8091 Zurich, Switzerland
[3] Univ Zurich Hosp, Dept Otorhinolaryngol, CH-8091 Zurich, Switzerland
[4] Kantonsspital, Dept Otorhinolaryngol, Luzern, Switzerland
[5] Kantonsspital, Inst Pathol, Luzern, Switzerland
[6] Kantonsspital Chur, Dept Otorhinolaryngol, Chur, Switzerland
[7] Kantonsspital Chur, Inst Pathol, Chur, Switzerland
[8] Univ Basel Hosp, Dept Otorhinolaryngol, CH-4031 Basel, Switzerland
[9] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland
[10] Kantonsspital, Dept Otorhinolaryngol, Aarau, Switzerland
[11] Kantonsspital, Inst Pathol, Aarau, Switzerland
关键词
D O I
10.1016/S1474-4422(03)00588-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Human prion disases are devastating and incurable, but are very rare. Fears that the bovine spongiform encephalopathy epizootic would lead to a large epidemic of its presumed human counterpart, variant Creutzfeldt-Jakob disease (vCJD), have not been realised. Yet a feeling of uncertainty prevails in the general public and in the biomedical world. The lack of data on the prevalence of asymptomatic carriers of vCJD compounds this uncertainty. In addition to this problem, Switzerland is currently faced with another issue of major public concern: a recent rise in the incidence of CJD. Here we examine the plausibility of several scenarios that may account for the increase in CJD incidence, including ascertainment bias due to improved reporting of CJD, iatrogenic transmission, and transmission of a prion zoonosis. In addition, we present the design and current status of a Swiss population-wide study of subclinical vCJD prevalence.
引用
收藏
页码:757 / 763
页数:7
相关论文
共 44 条
[31]   Accumulation of prion protein in tonsil and appendix: review of tissue samples [J].
Hilton, DA ;
Ghani, AC ;
Conyers, L ;
Edwards, P ;
McCardle, L ;
Penney, M ;
Ritchie, D ;
Ironside, JW .
BRITISH MEDICAL JOURNAL, 2002, 325 (7365) :633-634
[32]  
Hope J, 1999, J GEN VIROL, V80, P1, DOI 10.1099/0022-1317-80-1-1
[33]   Pathogenesis - HLA-DQ7 antigen and resistance to variant CJD [J].
Jackson, GS ;
Beck, JA ;
Navarrete, C ;
Brown, J ;
Sutton, PM ;
Contreras, M ;
Collinge, J .
NATURE, 2001, 414 (6861) :269-270
[34]   Soluble dimeric prion protein binds PrPSc in vivo and antagonizes prion disease [J].
Meier, P ;
Genoud, N ;
Prinz, M ;
Maissen, M ;
Rülicke, T ;
Zurbriggen, A ;
Raeber, AJ ;
Aguzzi, A .
CELL, 2003, 113 (01) :49-60
[35]   Impaired prion replication in spleens of mice lacking functional follicular dendritic cells [J].
Montrasio, F ;
Frigg, R ;
Glatzel, M ;
Klein, MA ;
Mackay, F ;
Aguzzi, A ;
Weissmann, C .
SCIENCE, 2000, 288 (5469) :1257-1259
[36]  
*OFF INT EP, BOV SPONG ENC BSE
[37]   MHC typing in variant Creutzfeldt-Jakob disease [J].
Pepys, MB ;
Bybee, A ;
Booth, DR ;
Bishop, MT ;
Will, RG ;
Little, AM ;
Prokupek, B ;
Madrigal, JA .
LANCET, 2003, 361 (9356) :487-489
[38]   NOVEL PROTEINACEOUS INFECTIOUS PARTICLES CAUSE SCRAPIE [J].
PRUSINER, SB .
SCIENCE, 1982, 216 (4542) :136-144
[39]   Prions [J].
Prusiner, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) :13363-13383
[40]   The impact of the introduction of the 14-3-3 protein assay in the surveillance of sporadic Creutzfeldt-Jakob disease in Catalonia [J].
Saiz, A ;
Nos, C ;
Yagüe, J ;
Dominguez, A ;
Graus, F ;
Muñoz, P .
JOURNAL OF NEUROLOGY, 2001, 248 (07) :592-594